BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15662957)

  • 1. Docking study of ligands into the colchicine binding site of tubulin.
    Farce A; Loge C; Gallet S; Lebegue N; Carato P; Chavatte P; Berthelot P; Lesieur D
    J Enzyme Inhib Med Chem; 2004 Dec; 19(6):541-7. PubMed ID: 15662957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxadiazole derivatives as a novel class of antimitotic agents: Synthesis, inhibition of tubulin polymerization, and activity in tumor cell lines.
    Ouyang X; Piatnitski EL; Pattaropong V; Chen X; He HY; Kiselyov AS; Velankar A; Kawakami J; Labelle M; Smith L; Lohman J; Lee SP; Malikzay A; Fleming J; Gerlak J; Wang Y; Rosler RL; Zhou K; Mitelman S; Camara M; Surguladze D; Doody JF; Tuma MC
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1191-6. PubMed ID: 16377187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of 1-methyl-2-(3',4',5'-trimethoxybenzoyl)-3-aminoindoles as a new class of antimitotic agents and tubulin inhibitors.
    Romagnoli R; Baraldi PG; Sarkar T; Carrion MD; Cara CL; Cruz-Lopez O; Preti D; Tabrizi MA; Tolomeo M; Grimaudo S; Di Cristina A; Zonta N; Balzarini J; Brancale A; Hsieh HP; Hamel E
    J Med Chem; 2008 Mar; 51(5):1464-8. PubMed ID: 18260616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational comparison of microtubule-stabilising agents laulimalide and peloruside with taxol and colchicine.
    Pineda O; Farràs J; Maccari L; Manetti F; Botta M; Vilarrasa J
    Bioorg Med Chem Lett; 2004 Oct; 14(19):4825-9. PubMed ID: 15341932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structures of a diverse set of colchicine binding site inhibitors in complex with tubulin provide a rationale for drug discovery.
    Wang Y; Zhang H; Gigant B; Yu Y; Wu Y; Chen X; Lai Q; Yang Z; Chen Q; Yang J
    FEBS J; 2016 Jan; 283(1):102-11. PubMed ID: 26462166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tubulin agents of natural origin: Targeting taxol, vinca, and colchicine binding domains.
    Naaz F; Haider MR; Shafi S; Yar MS
    Eur J Med Chem; 2019 Jun; 171():310-331. PubMed ID: 30953881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, antiproliferative activity and molecular docking of Colchicine derivatives.
    Huczyński A; Majcher U; Maj E; Wietrzyk J; Janczak J; Moshari M; Tuszynski JA; Bartl F
    Bioorg Chem; 2016 Feb; 64():103-12. PubMed ID: 26794327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indirubin, a bis-indole alkaloid binds to tubulin and exhibits antimitotic activity against HeLa cells in synergism with vinblastine.
    Mohan L; Raghav D; Ashraf SM; Sebastian J; Rathinasamy K
    Biomed Pharmacother; 2018 Sep; 105():506-517. PubMed ID: 29883946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and structure-activity relationships of 1-benzyl-4,5,6-trimethoxyindoles as a novel class of potent antimitotic agents.
    Lai MJ; Kuo CC; Yeh TK; Hsieh HP; Chen LT; Pan WY; Hsu KY; Chang JY; Liou JP
    ChemMedChem; 2009 Apr; 4(4):588-93. PubMed ID: 19266513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of a fluorescent derivative of paclitaxel (Taxol) with microtubules and tubulin-colchicine.
    Han Y; Chaudhary AG; Chordia MD; Sackett DL; Perez-Ramirez B; Kingston DG; Bane S
    Biochemistry; 1996 Nov; 35(45):14173-83. PubMed ID: 8916903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of 2- and 3-aminobenzo[b]thiophene derivatives as antimitotic agents and inhibitors of tubulin polymerization.
    Romagnoli R; Baraldi PG; Carrion MD; Lopez Cara C; Preti D; Fruttarolo F; Pavani MG; Tabrizi MA; Tolomeo M; Grimaudo S; Di Cristina A; Balzarini J; Hadfield JA; Brancale A; Hamel E
    J Med Chem; 2007 May; 50(9):2273-7. PubMed ID: 17419607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and Antiproliferative Screening Of Novel Analogs of Regioselectively Demethylated Colchicine and Thiocolchicine.
    Czerwonka D; Sobczak S; Maj E; Wietrzyk J; Katrusiak A; Huczyński A
    Molecules; 2020 Mar; 25(5):. PubMed ID: 32151042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interaction of the B-ring of colchicine with alpha-tubulin: a novel footprinting approach.
    Chaudhuri AR; Seetharamalu P; Schwarz PM; Hausheer FH; Ludueña RF
    J Mol Biol; 2000 Nov; 303(5):679-92. PubMed ID: 11061968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxybenzoyl)-6-substituted-4,5,6,7-tetrahydrothieno[2,3-c]pyridine derivatives as antimitotic agents and inhibitors of tubulin polymerization.
    Romagnoli R; Baraldi PG; Carrion MD; Cruz-Lopez O; Cara CL; Tolomeo M; Grimaudo S; Di Cristina A; Pipitone MR; Balzarini J; Kandil S; Brancale A; Sarkar T; Hamel E
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5041-5. PubMed ID: 18725179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Free energy calculations on the binding of colchicine and its derivatives with the alpha/beta-tubulin isoforms.
    Mane JY; Klobukowski M; Huzil JT; Tuszynski J
    J Chem Inf Model; 2008 Sep; 48(9):1824-32. PubMed ID: 18712858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benomyl and colchicine synergistically inhibit cell proliferation and mitosis: evidence of distinct binding sites for these agents in tubulin.
    Clément MJ; Rathinasamy K; Adjadj E; Toma F; Curmi PA; Panda D
    Biochemistry; 2008 Dec; 47(49):13016-25. PubMed ID: 19049291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The betaI/betaIII-tubulin isoforms and their complexes with antimitotic agents. Docking and molecular dynamics studies.
    Magnani M; Ortuso F; Soro S; Alcaro S; Tramontano A; Botta M
    FEBS J; 2006 Jul; 273(14):3301-10. PubMed ID: 16803461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Tubulin-colchicine Site for Cancer Therapy: Inhibitors, Antibody- Drug Conjugates and Degradation Agents.
    Duan Y; Liu W; Tian L; Mao Y; Song C
    Curr Top Med Chem; 2019; 19(15):1289-1304. PubMed ID: 31210108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel antimitotic agents related to tubuloclustin: synthesis and biological evaluation.
    Zefirova ON; Nurieva EV; Wobith B; Gogol VV; Zefirov NA; Ogonkov AV; Shishov DV; Zefirov NS; Kuznetsov SA
    Mol Divers; 2017 Aug; 21(3):547-564. PubMed ID: 28484934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimitotic antifungal compound benomyl inhibits brain microtubule polymerization and dynamics and cancer cell proliferation at mitosis, by binding to a novel site in tubulin.
    Gupta K; Bishop J; Peck A; Brown J; Wilson L; Panda D
    Biochemistry; 2004 Jun; 43(21):6645-55. PubMed ID: 15157098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.